AI is becoming an increasingly important tool for drug discovery. However, for many pharmaceutical and biotech companies, the challenge isn’t finding more powerful models. It’s getting existing models to work together with proprietary research data and computing infrastructure in a way that’s actually useful for scientists. That is exactly the problem Databricks and Nvidia are [...]